Background: Oseltamivir (Tamiflu), a neuraminidase inhibitor, was approved by the FDA in 1999. The majority of the evidence supporting the use of the medication came from trials funded by Roche, the maker of the drug. Safety issues with the drug …
Background: Headache is a common presentation to the emergency department (ED) accounting for 2% of all visits [1]. Of the patients that present with headache,1 – 3% will be due to a subarachnoid hemorrhage (SAH) [1]. SAH is a true diagnostic …
Background: CT coronary angiography (CTCA) is a relatively new technology that has gained popularity over the past few years in evaluating patients presenting with chest pain. CTCA is an anatomic test that has been shown to increase downstream testing and increase healthcare …
This year ACEP 2018 took place in San Diego, CA from Oct 1st– 4th, 2018. There were lots of amazing speakers and topics as was evidenced by the eruption of everyone’s twitter feeds with the #ACEP18 hashtag. I was fortunate …
Background: CCTA has become a popular modality in the ED setting to assess anatomic atherosclerotic disease in patients presenting with chest pain. Advocates of CCTA feel that CCTA has a greater accuracy in identifying obstructive coronary artery disease and identification of …
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.
